Cardiovascular Disease in T2D: Researchers Identify Potential Therapeutic Target for Underlying Cause
Cardiovascular Disease in T2D: Researchers Identify Potential Therapeutic Target for Underlying Cause
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
AHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD
AHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD
CKM Syndrome Linked to Heart, Kidney, and Metabolic Diseases
CKM Syndrome Linked to Heart, Kidney, and Metabolic Diseases
Pharmacist-Prescribing and Hypertension Management: An Economic Benefit
Pharmacist-Prescribing and Hypertension Management: An Economic Benefit
SELECT Trial: Semaglutide Lowers CVD Risk in Patients with Obesity
SELECT Trial: Semaglutide Lowers CVD Risk in Patients with Obesity
Main Messages of New ESC Guidelines for CVD Management in Diabetes
Main Messages of New ESC Guidelines for CVD Management in Diabetes
Update of ESC Guidelines on Heart Failure in a Nutshell
Update of ESC Guidelines on Heart Failure in a Nutshell
First ESC Guidelines on Cardiomyopathies Management
First ESC Guidelines on Cardiomyopathies Management
First ESC Guidelines on Cardiomyopathies - Diagnosis
First ESC Guidelines on Cardiomyopathies - Diagnosis
Combined ESC Guidelines for the Entire ACS Spectrum
Combined ESC Guidelines for the Entire ACS Spectrum
Transformation of Treatment Strategies for ATTR Amyloidosis
Transformation of Treatment Strategies for ATTR Amyloidosis
Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity
Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity
A Discussion on Statins to Lower CVD Risk for HIV Patients
A Discussion on Statins to Lower CVD Risk for HIV Patients
